graphic image of China flags overlapping with US flags
Biotech

Pfizer pens $10B, 12-drug deal with Innovent

Pfizer is paying $650 million upfront and proposing four discovery programs, while Innovent is contributing eight early-stage assets.
Nick Paul Taylor May 29, 2026 4:05am
Bristol Myers Squibb booth at AACR 2026

ASCO: BMS CELMoD drug doubles PFS in ‘incredibly exciting’ ph. 3

May 29, 2026 8:00am
Gilead

Gilead scraps lead arthritis drug from $405M MiroBio buyout

May 29, 2026 7:18am
Eli Lilly booth at AACR 2026

ASCO: Lilly debuts ‘strong’ data for potential Padcev challenger

May 29, 2026 8:00am
An artists 3D rendering of cancerous blood cells among healthy red blood cells The cells fill the image and are of various

Agios’ next-gen PK drug fails ph. 2 blood cancer study

May 29, 2026 9:13am
success failure signposts

AstraZeneca, after phase 3 miss, posts data behind approval bid

May 29, 2026 10:15am
More News

Boston, China and the future of biotech

May 29, 2026 9:09am

Allogene swaps in CMO as new chief exec—Chutes & Ladders

May 29, 2026 8:30am

FDA extends Beren’s rare disease review after info request

May 28, 2026 10:45am

Icon ends accounting investigation, finds overstated revenue

May 28, 2026 10:31am